• English
  • Deutsch
  • Log In
    Password Login
    or
  • Research Outputs
  • Projects
  • Researchers
  • Institutes
  • Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Proteolytic a-Synuclein Cleavage in Health and Disease
 
  • Details
  • Full
Options
2021
Journal Article
Titel

Proteolytic a-Synuclein Cleavage in Health and Disease

Abstract
In Parkinson's disease, aggregates of a-synuclein within Lewy bodies and Lewy neurites represent neuropathological hallmarks. However, the cellular and molecular mechanisms triggering oligomeric and fibrillary a-synuclein aggregation are not fully understood. Recent evidence indicates that oxidative stress induced by metal ions and post-translational modifications such as phosphorylation, ubiquitination, nitration, glycation, and SUMOylation affect a-synuclein conformation along with its aggregation propensity and neurotoxic profiles. In addition, proteolytic cleavage of a-synuclein by specific proteases results in the formation of a broad spectrum of fragments with consecutively altered and not fully understood physiological and/or pathological properties. In the present review, we summarize the current knowledge on proteolytical a-synuclein cleavage by neurosin, calpain-1, cathepsin D, and matrix metalloproteinase-3 in health and disease. We also shed light on the contribution of the same enzymes to proteolytical processing of pathogenic proteins in Alzheimer's disease and report potential cross-disease mechanisms of pathogenic protein aggregation.
Author(s)
Bluhm, Alexandra
Universität Leipzig
Schrempel, Sarah
Universität Leipzig
Hörsten, Stephan von
Universität Erlangen-Nürnberg
Schulze, Anja
Fraunhofer IZI-MWT
Roßner, Steffen
Universität Leipzig
Zeitschrift
International journal of molecular sciences
Thumbnail Image
DOI
10.3390/ijms22115450
Externer Link
Externer Link
Language
English
google-scholar
Fraunhofer-Institut für Zelltherapie und Immunologie IZI
Tags
  • Tiermodell

  • Lewy-Body-Demenz

  • Parkinson's disease

  • Post-translational modification

  • Proteolysis

  • Substantia nigra

  • a‐synuclein

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Send Feedback
© 2022